Edwin de Zwart

465 citations

7 papers · 356 indexed · h-index 6

Co-authors: Allard Kaptein Tjeerd Barf Bas van de Kar Bart van Lith Michael Gulrajani Todd Covey Fanny Krantz Raquel Izumi
Topics: Chronic Lymphocytic Leukemia Research (3 papers)Synthesis and biological activity (2 papers)Lymphoma Diagnosis and Treatment (2 papers)
Cited by: Genetics Pathology and Forensic Medicine Hematology
Journals: Cancer Research Journal of Pharmacology and Experimental Therapeutics Bioorganic & Medicinal Chemistry Letters
Partner nations: United States Netherlands

In The Last Decade

Edwin de Zwart

7 papers receiving 346 citations

Peers

Countries citing papers authored by Edwin de Zwart

Since Specialization

Citations

This map shows the geographic impact of Edwin de Zwart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin de Zwart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin de Zwart more than expected).

Fields of papers citing papers by Edwin de Zwart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin de Zwart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin de Zwart. The network helps show where Edwin de Zwart may publish in the future.

Co-authorship network of co-authors of Edwin de Zwart

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin de Zwart. A scholar is included among the top collaborators of Edwin de Zwart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin de Zwart. Edwin de Zwart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Discovery and optimization of covalent EGFR T790M/L858R mutant inhibitors 2021 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Dennis Demont,Edwin de Zwart,(unknown),(unknown),Bas van de Kar,Allard Kaptein,Tjeerd Barf	2
2	Discovery of quinoline-based irreversible BTK inhibitors 2020 ·Bioorganic & Medicinal Chemistry Letters ·Gerjan de Bruin,Dennis Demont,Edwin de Zwart,(unknown),(unknown),Bas van de Kar,Bart van Lith,(unknown),Michael Gulrajani,Todd Covey,Allard Kaptein,Tjeerd Barf	7
3	Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile 2017 ·Journal of Pharmacology and Experimental Therapeutics ·Tjeerd Barf,Todd Covey,Raquel Izumi,Bas van de Kar,Michael Gulrajani,Bart van Lith,(unknown),Edwin de Zwart,Diana Mittag,Dennis Demont,(unknown),Fanny Krantz,Paul G. Pearson,Roger G. Ulrich,Allard Kaptein	272
4	Abstract 2596: ACP-196: a novel covalent Bruton's tyrosine kinase (Btk) inhibitor with improved selectivity and in vivo target coverage in chronic lymphocytic leukemia (CLL) patients 2015 ·Cancer Research ·Todd Covey,Tjeerd Barf,Michael Gulrajani,Fanny Krantz,Bart van Lith,Елена Бибикова,Bas van de Kar,Edwin de Zwart,Ahmed Hamdy,Raquel Izumi,Allard Kaptein	36
5	Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series 2011 ·Bioorganic & Medicinal Chemistry Letters ·Arthur Oubrie,Allard Kaptein,Edwin de Zwart,(unknown),(unknown),Bas van de Kar,(unknown),(unknown),(unknown),(unknown),Bert Kazemier,(unknown),(unknown),Jos P. M. Lommerse,Carsten Schultz‐Fademrecht,Tjeerd Barf	13
6	Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Allard Kaptein,Arthur Oubrie,Edwin de Zwart,(unknown),(unknown),Bas van de Kar,(unknown),(unknown),(unknown),Carsten Schultz‐Fademrecht,(unknown),(unknown),(unknown),Bert Kazemier,(unknown),(unknown),John Dulos,Martin Jaeger,(unknown),Tjeerd Barf	17
7	Solution-phase and solid-phase synthesis of novel transition state inhibitors of coagulation enzymes incorporating a piperidinyl moiety 1999 ·Bioorganic & Medicinal Chemistry Letters ·Anton E.P. Adang,(unknown),(unknown),Edwin de Zwart,G.H. Veeneman	9

About Edwin de Zwart

Edwin de Zwart is a scholar working on Genetics, Pathology and Forensic Medicine and Organic Chemistry, having authored 7 papers that have together received 356 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (3 papers), Synthesis and biological activity (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (252 citations), Pathology and Forensic Medicine (191 citations) and Hematology (106 citations). Edwin de Zwart has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Allard Kaptein, Tjeerd Barf, Bas van de Kar, Bart van Lith, Michael Gulrajani, Todd Covey, Fanny Krantz, Raquel Izumi, Dennis Demont and Diana Mittag. Their work appears in journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact